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Abstract 
Background: Up to 90 % of the global burden of malaria morbidity and mortality occurs in sub-Saharan Africa and 
children under-five bear a disproportionately high malaria burden. Effective inpatient case management can reduce 
severe malaria mortality and morbidity, but there are few reports of how successfully international and national rec-
ommendations are adopted in management of inpatient childhood malaria.
Methods: A descriptive cross-sectional study of inpatient malaria case management practices was conducted using 
data collected over 24 months in five hospitals from high malaria risk areas participating in the Clinical Information 
Network (CIN) in Kenya. This study describes documented clinical features, laboratory investigations and treatment of 
malaria in children (2–59 months) and adherence to national guidelines.
Results: A total of 13,014 children had a malaria diagnosis on admission to the five hospitals between March, 2014 
and February, 2016. Their median age was 24 months (IQR 12–36 months). The proportion with a diagnostic test for 
malaria requested was 11,981 (92.1 %). Of 10,388 patients with malaria test results documented, 8050 (77.5 %) were 
positive and anti-malarials were prescribed in 6745 (83.8 %). Malaria treatment was prescribed in 1613/2338 (69.0 %) 
children with a negative malaria result out of which only 52 (3.2 %) had a repeat malaria test done as recommended 
in national guidelines. Documentation of clinical features was good across all hospitals, but quinine remained the 
most prescribed malaria drug (47.2 % of positive cases) although a transition to artesunate (46.1 %) was observed. 
Although documented clinical features suggested approximately half of positive malaria patients were not severe 
cases artemether-lumefantrine was prescribed on admission in only 3.7 % cases.
Conclusions: Despite improvements in inpatient malaria care, high rates of presumptive treatment for test negative 
children and likely over-use of injectable anti-malarial drugs were observed. Three years after national policy change, 
there is a gradual transition to artesunate. Continued efforts to support improved routine inpatient malaria care 
through dissemination and implementation of guidelines, and access to recommended drugs are needed together 
with improved capacity of hospitals to investigate other causes of severe illness in children. Efforts to improve clinical 
information could help track progress.
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Background
Worldwide estimates indicate that three-quarters of 
malaria infections involving children under-5 years occur 
in sub-Saharan Africa [1]. Malaria case management 
backed up with rapid diagnostics or laboratory investi-
gations is the main strategy for treating malaria in low-
income countries [2]. The case management strategy 
promoted by the World Health Organization (WHO) 
is based on well-described clinical features of severe 
malaria [3–6] and effectiveness trials of recommended 
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treatments [7]. The WHO in 2010, revised its treatment 
policy to recommend universal testing for all suspected 
malaria cases prior to treatment, and replacement of the 
then existing first-line anti-malarial drugs with new ther-
apies in both outpatient and inpatient malaria treatment 
[8, 9]. These recommendations were adopted in Kenya 
in 2010 [10] and in 2012 [11], but although reports of 
outpatient malaria treatment change from sulfadoxine-
pyrimethamine (SP) to artemisinin-based combination 
therapy (ACT) show major improvements in quality of 
malaria case management, significant challenges includ-
ing drug stock-outs still persist [12, 13].
In the inpatient setting such assessments are rare. 
Existing primary studies on inpatient malaria treatment 
suggest a need to consider the wider clinical decision-
making context in addition to simple dissemination of 
clinical guidelines [14, 15]. Similarly, systematic reviews 
indicate that clinical guidelines have a variable effect 
on uptake of new drugs and diagnostics in secondary 
care (equivalent to County Hospitals in Kenya). Among 
the factors that have been postulated to have an effect 
on guideline implementation especially with regard to 
uptake of new drugs and diagnostics is strong profes-
sional networks [16]. Descriptive analysis of inpatient 
childhood malaria treatment practices in Kenyan hospi-
tals in the period following treatment guidelines amend-
ments in Kenya was done. Data obtained from the 
recently established paediatric Clinical Information Net-
work in Kenya were used to examine adoption of malaria 
guidelines which recommend parasitological diagnosis of 
malaria, adherence to test results, and use of injectable 
artesunate and not quinine in treatment [9, 17, 18].
Methods
Study design and setting
This was a descriptive cross sectional study. A subset of 
the data from five of the 14 hospitals participating in the 
CIN collected during a 24-month period (March, 2014 
to February, 2016) was used. All the five hospitals are 
located in the western Kenya, a high malaria prevalence 
region and serve predominantly poor populations.
Participants
All children aged between 2 and 59 months admitted to 
the paediatric wards in the participating hospitals with 
a diagnosis of malaria were eligible for inclusion in the 
study.
Data collection and management
Since its establishment in October 2013 CIN has sup-
ported data capture from paediatric medical records 
that include a standardised admission record form using 
the non-proprietary Research Electronic Data Capture 
(REDCap) tool in all participating hospitals [17]. Sup-
port provided to hospitals participating in the network 
includes an additional post for a clerical assistant in each 
hospital and provision of one basic computer. Data col-
lection is done on a daily basis by the clerk from medical 
records of all admitted patients in paediatric wards using 
detailed standard operating procedures under the joint 
supervision of the hospital medical records department 
and the CIN team. Data quality is promoted through the 
use of range and quality checks in the electronic data 
tool and error checking procedures. The details of data 
management have been previously published [17]. In 
brief, a process for validating the data collected at each 
site is conducted bimonthly through conducting double 
entry for selected records. During the validation at least 
140 records previously entered by CIN data clerks in the 
2-month period prior to the validation are re-entered by 
an independent trained data collection team. Ten records 
are selected at random for re-entry at each hospital (giv-
ing a total of 140 records across the network). Analysis is 
then done to validate data using R scripts that conduct 
field by field comparison for all fields in the database. A 
total concordance score is then calculated for each record 
and feedback is immediately given to data clerks in areas 
where there is discordance between the two sets of 
entries. During the most recent round of data validation 
the overall concordance was 85 %.
Statistical analysis
No formal sample size calculations were undertaken, 
but data on over 13,000 children aged between 2 and 
59 months with an admission diagnosis of malaria were 
considered adequate to provide reasonably precise esti-
mates around malaria case management practices. 
Descriptive analysis of the malaria admissions pooled 
across all hospitals and for each hospital included cal-
culating frequencies, relative frequencies and medians 
(IQR) for categorical and continuous variables, respec-
tively. Indicators of good practice for five key areas of 
inpatient malaria case management spanning clinical 
assessment, laboratory investigation and treatment are 
defined in Table 1 and proportions of patients managed 
according to the current malaria guidelines are reported. 
The proportion of children for whom six specific features 
of malaria were assessed and documented in medical 
records was calculated. The level of adherence to para-
sitological testing recommendations was determined by 
calculating the percentage of malaria admissions with 
parasitological confirmation at the time of initiating 
anti-malarial drugs. Finally, for parenteral anti-malarials 
the proportion with the correct dosages based on body 
weight (drug dose per kg body weight), allowing for 
the dosage to be within 20  % of recommended dosage 
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(guideline dosage ± 20 %) were calculated. No attempts 
were made to impute data where these data were miss-
ing for calculating specific indicators (for example if the 
child’s weight was missing correctness of drug dosage 
could not be estimated). In addition, the following indi-
cators were used to assess the routine practice of using 
laboratory testing to guide management; proportion with 
laboratory requests of haemoglobin level, blood chemis-
try and glucose level. To identify evidence that clinicians 
considered other causes of febrile illnesses the proportion 
of malaria patients with the following tests requested: 
HIV status, blood culture/lumbar culture, x-rays and 
urine tests and the proportions prescribed antibiotics 
were calculated. All analyses were conducted using R sta-
tistical software (version 3.2.2) [19].
Ethical consideration
Scientific and ethical approval for the study was obtained 
from the Kenya Medical Research Institute Scientific and 
Ethics Review Unit as part of the CIN study (SSC proto-
col no. 2465) that provides for use of de-identified patient 
data obtained through retrospective review of medical 
records without individual informed consent for audit 
and quality improvement purposes.
Results
Malaria diagnosis and clinical features
During the 24-month period, there were 19,419 acute 
medical admissions out of which 13,014 (67 %) children 
had admission diagnosis of malaria (range 1597–4572 per 
hospital). The median age of malaria admissions across 
all hospitals was 24 months (interquartile range 12–36), 
and 53  % were male. Fever was a common present-
ing feature, 91.6 % of malaria admissions with complete 
documentation had fever (from 84.8 to 95.7  % per hos-
pital). Documentation of the specific guideline recom-
mended signs of severe malaria (fever, pallor, altered 
consciousness level, respiratory distress, ability to drink 
and convulsions) within the medical records of malaria 
admissions ranged from 10 to 100 % for the specific signs 
across hospitals (Fig. 1), and rapid improvements in doc-
umentation of malaria features was noted in three hos-
pitals upon joining the CIN. Documentation of the five 
signs was 70  % with a range of 47.2–83.6  % across the 
hospitals. WHO defined severe malaria (characterized 
by the occurrence of danger signs of severe illness in a 
child with malaria diagnosis) was common with 49.4  % 
of malaria admissions presenting with at least one danger 
sign. The specific danger signs for malaria were present 
in between 8.1 and 34.8 % of admissions seen during the 
entire period: convulsions (34.8  %), respiratory distress 
(14.8 %), severe pallor (14.6 %), and altered level of con-
sciousness (8.1 %) (Table 2).
Investigation of admissions with clinical malaria
Of all the 13,014 admissions with clinical malaria, 11,981 
(92.1  %) had a malaria test ordered during admission 
(range per hospital 82.5 to 98.7 %). Further, among these 
children with a malaria test requested 10,388/11,981 
(86.7 %) had malaria test results documented in the clini-
cal notes (range per hospital 66.6–99.3 %).
The majority, 8050/10,388 (77.5  %) of documented 
malaria test results were positive for the malaria parasite. 
For those with negative malaria tests still treated pre-
sumptively, 52/1613 (3.2  %, hospitals’ range 0–17.6  %), 
had malaria diagnostic tests repeated (Table 3). To guide 
management decisions in the children with malaria 
diagnosis (N  =  13,014) the following tests were done; 
Table 1 Malaria policy recommendations and the indicators used to assess implementation and adherence
Policy recommendation Indicator
All key clinical features of severe malaria should be assessed and docu-
mented
Proportion among the children with a diagnosis of malaria with 
documented assessment of the following clinical features: level of con-
sciousness (AVPU scale), deep acidotic breathing or chest in-drawing 
(respiratory distress), fever, ability to drink, convulsions and pallor
All suspected malaria cases without a sign of severe disease should have 
parasitological confirmation by diagnostic testing before initiating treat-
ment
Proportion of patients with a diagnosis of malaria with a malaria test 
ordered on the admission date and with the results recorded in the 
medical notes or laboratory register
Malaria positive cases should be prescribed anti-malarial drug Proportion with malaria positive test prescribed anti-malarials
Proportion with malaria negative test prescribed anti-malarials
Type of anti-malarial drugs prescribed
Anti-malarial drug dosages; Quinine loading dose of 20 mg, maintenance 
dose of 10 mg and artesunate at 2.4 mg per kg body weight with a 20 % 
margin of error
Proportion with malaria positive prescribed quinine or artesunate and 
proportions with correct dosing
Management of malaria negative; anti-malarial drugs should be withheld in 
non-severe malaria cases with a negative test; those with signs of severe 
malaria be started on presumptive treatment but testing should be 
repeated
Proportion of patients with admission diagnosis of severe malaria but a 
negative admission test and given anti-malarials who had repeat test-
ing after admission
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haemoglobin level 4626 (35.5  %), blood chemistry 178 
(1.4  %) and blood glucose 333 (2.6  %). Among the chil-
dren documented to have severe pallor, 1232/1583 
(77.8 %) had haemoglobin level checked. Other diagnos-
tic tests done included: HIV status ascertained (39.6 %), 
microbiology (blood culture or lumbar puncture for 
CSF culture and other microscopic and biochemical 
CSF investigations) (8.5 %), urine tests (1.9 %) and x-rays 
(2.5 %).
Treatment of malaria cases
A total of 6745/8050 (83.8  %) patients with a posi-
tive malaria test were clearly prescribed anti-malarials. 
Among the remaining 1305 (16.2 %) a total of 1120/1305 
(85.8  %) had no treatment information available. Of 
the 2338 patients with a negative diagnostic test, 1613 
(69.0  %, range across hospitals 53.0–80.2  %) were pre-
scribed anti-malarials out of which 1065 (66.0  %) had 
signs or a diagnosis of severe malaria and only 37 (3.5 %) 
had a repeat test done with 28 (75.7  %) being positive. 
There were 1033 (7.9 %) children who were not tested for 
malaria and of these 786 (76.1 %) had anti-malarials pre-
scribed. The anti-malarial drugs and formulations used 
were tablets for oral artemether-lumefantrine and injec-
tions for quinine, artemether and artesunate. Among the 
cases with a positive malaria test given anti-malarials on 
admission (n =  6745), quinine was the most prescribed 
drug in 3184 (47.2  %), followed by artesunate in 3108 
Fig. 1 Temporal trend in documentation of clinical signs from March, 2014 to February, 2016
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Table 2 Demographic characteristics and clinical signs of childhood malaria in children admitted to five Kenyan County 
Hospitals
IQR interquartile range
a,b The denominator for proportion with clinical signs of malaria where the respective sign was documented
Indicator Overall Hospitals
H1 H3 H7 H8 H13
Number of malaria cases 13014 2587 4572 1695 2563 1597
Male (%) 6880/13014 (52.9) 1388/2587 (53.7) 2430/4572 (53.1) 877/1695 (51.7) 1361/2563 (53.1) 824/1597 (51.6)
Age in months, median (IQR) 24 (12–36) 20 (12–36) 23 (12–36) 20 (11–36) 15 (9–27) 24 (12–36)
All clinical features documented 9104/13014 (70.0) 2013 (77.8) 3169 (69.3) 800 (47.2) 2143 (83.6) 979 (61.3)
Malaria admissions with fevera (%) 10063/10981 (91.6) 2132/2255 (94.5) 3527/3854 (91.5) 1260/1317 (95.7) 1890/2229 (84.8) 1254/1326 (94.6)
Malaria admissions with at least one 
danger signb (%)
6427/13014 (49.4) 1412/2587 (54.6) 2204/4572 (48.2) 675/1695 (39.8) 1185/2563 (46.2) 951/1597 (59.5)
Altered level of consciousness (%) 863/10600 (8.1) 195/2160 (9.0) 288/3828 (7.5) 74/1227 (6.0) 145/2201 (6.6) 161/1184 (13.6)
Inability to drink (%) 1264/9514 (13.3) 369/2111 (17.5) 244/3370 (7.2) 137/857 (16.0) 272/2121 (12.8) 242/1055 (22.9)
Respiratory distress (%) 1435/9692 (14.8) 266/2161 (12.3) 405/3373 (12.0) 61/895 (6.8) 539/2185 (24.7) 164/1078 (15.2)
Severe pallor (%) 1583/10807 (14.6) 383/2180 (17.6) 795/3848 (20.7) 171/1281 (13.3) 103/2202 (4.7) 131/1296 (10.1)
Convulsions (%) 3699/10625 (34.8) 775/2205 (35.1) 1227/3721 (33.0) 427/1196 (35.7) 555/2223 (25.0) 715/1280 (55.9)
Table 3 Malaria testing and treatment practices among children admitted to five Kenyan County Hospitals: March, 2014 
to February, 2016
a Broad spectrum antibiotics including crystalline penicillin, gentamicin, ceftriaxone, amoxicillin or chloramphenicol was prescribed
Indicator Overall H1 H3 H7 H8 H13
Total malaria admissions (N) 13014 2587 4572 1695 2563 1597
Malaria investigations
Proportion with malaria test 
requested, n/N (%)
11981/13014 (92.0) 2533/2587 (97.9) 3770/4572 (82.5) 1596/1695 (94.2) 2505/2563 (97.7) 1577/1597 (98.7)
Malaria test results available, n/N (%) 10388/11981 (86.7) 2516/2533 (99.3) 2510/3770 (66.6) 1481/1596 (92.8) 2327/2505 (92.9) 1554/1577 (98.5)
Positive malaria test in those with 
results documented, n/N (%)
8050/10388 (77.5) 1902/2516 (75.6) 2046/2510 (81.5) 1162/1481 (78.5) 1609/2327 (69.1) 1331/1554 (85.6)
Positive malaria test in all children 
diagnosed with malaria, n/N (%)
8050/13014 (61.9) 1902/2587 (73.5) 2046/4572 (44.8) 1162/1695 (68.6) 1609/2563 (62.8) 1331/1597 (83.3)
Diagnosis of severe malaria with 
positive test, n/N (%)
5243/8050 (65.1) 1174/1902 (61.7) 1701/2046 (83.1) 699/1162 (60.2) 793/1609 (49.3) 876/1331 (65.8)
Antimalarial prescription
Proportion with positive test pre-
scribed anti-malarial drug, n/N (%)
6745/8050 (83.8) 1642/1902 (86.3) 1760/2046 (86.0) 909/1162 (78.2) 1347/1609 (83.7) 1087/1331 (81.7)
Proportion with negative test pre-
scribed anti-malarial drug, n/N (%)
1613/2338 (69.0) 479/614 (78.0) 372/464 (80.2) 169/319 (53.0) 445/718 (62.0) 148/223 (66.4)
Proportion of negative test treated 
presumptively with repeat testing, 
n/N (%)
52/1613 (3.2) 7/479 (1.5) 0 1/169 (0.6) 18/445 (4.0) 26/148 (17.6)
Proportion with no malaria test 
treated presumptively, n/N (%)
786/1033 (76.1) 28/54 (51.9) 674/802 (84.0) 45/99 (45.5) 35/58 (60.3) 4/20 (20.0)
Antibiotic prescription
Proportion of all malaria admission 
cases prescribed antibioticsa, n/N 
(%)
6966/13014 (53.5) 1428/2587 (55.2) 2615/4572 (57.2) 609/1695 (35.9) 1555/2563 (60.7) 759/1597 (47.5)
Proportion with positive test pre-
scribed antibioticsa, n/N (%)
4041/8050 (50.2) 1025/1902 (53.9) 1122/2046 (54.8) 369/1162 (31.8) 920/1609 (57.2) 605/1331 (45.5)
Proportion with negative prescribed 
antibioticsa, n/N (%)
1463/2338 (62.6) 368/614 (59.9) 290/464 (62.5) 172/319 (53.9) 497/718 (69.2) 136/223 (61.0)
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(46.1 %) and the least prescribed drug on admission was 
artemether-lumefantrine in 250 (3.7 %) (Table 4). Hospi-
tals most commonly prescribed parenteral quinine except 
H8 where 89.0 % were prescribed artesunate (see Fig. 2). 
For children with a negative malaria test given anti-
malarials (n = 1613), artesunate was the most prescribed 
drug 845 (52.4 %) followed by quinine 597 (37.0 %).
Among all malaria cases who were prescribed quinine, 
59.1  % of the loading and 93.1  % of the maintenance 
doses were correct. Approximately two-thirds (63.8  %) 
of children given artesunate were prescribed the recom-
mended dose.
Prescription patterns of anti-malarial drugs varied by 
hospital and by time (Fig.  2). In H1 and H3 they alter-
nated between quinine and artesunate. Prescription of 
artesunate was consistently high in H8, whereas H3, 
H7 and H13 transitioned to use of artesunate during 
the monitoring period. Among the cases who were pre-
scribed either quinine or artesunate, (n  =  9840), 7598 
(77.2  %) had signs suggestive of severe or complicated 
malaria or a diagnosis of severe malaria. Anti-malarial 
prescription rates for children with a negative test ranged 
between 15 and 100  % across the hospitals throughout 
the period. Antibiotics prescription among the patients 
testing negative and positive for malaria was 62.6 and 
50.2 %, respectively (Table 3).
Discussion
The aim of this study was to determine the investigation 
and treatment practices for children aged 2–59  months 
admitted with malaria in Western Kenya County hospi-
tals 3 and 4 years after national and international malaria 
guidelines changed respectively. Documentation of clini-
cal features of malaria (whether present or absent) was 
good, including the signs that define severe malaria; level 
of consciousness and respiratory distress [10]. This is 
an improvement compared to an earlier studies done in 
Kenya [20], Uganda [21] and in Benin [22], and is likely 
due to routine use of a structured Paediatric Admission 
Record (PAR) that guides junior clinicians to conduct a 
complete physical examination of sick children at admis-
sion [23, 24] associated with feedback on documentation 
quality given to hospitals in the form of two monthly 
reports [17]. Malaria laboratory testing rates when com-
mencing inpatient treatment for clinical malaria were 
92 % with recording of diagnostic test results in medical 
notes found in over three quarters. Findings on rates of 
testing and reporting are similar to some recent stud-
ies in Uganda [25] and Benin [22], but better than other 
studies from the region and earlier studies from Kenya 
[20, 23, 26–28]. Findings therefore suggest some success 
in adoption of the test and treat approach.
Over 80  % of malaria positive cases were clearly pre-
scribed anti-malarial drugs. However, almost half were 
prescribed intravenous quinine despite the change in 
recommendations to use of artesunate in 2012. The 
trend was consistent across all the hospitals in the begin-
ning of the period except H8 where most patients were 
given artesunate throughout the study period. In addi-
tion, there was a shift towards intravenous artesunate 
towards the end of the period in H3, H7 and H13. Similar 
results were reported in Uganda [25] and although the 
use of artesunate in 2014/2016 is unsatisfactory it is an 
improvement on a 2012 Kenyan survey when no inpa-
tient malaria patients were given artesunate [23]. Infor-
mal enquiries through hospital staff indicated that the 
consistent prescription of artesunate in H8 was because 
of local efforts to ensure consistent drug availability 
(including local purchase). The lower rates of prescrib-
ing artesunate in other facilities were in part attributed to 
stock outs as well as continued difficulties changing pre-
scribing habits.
While there is a transition from quinine to artesunate 
almost half of the clinical malaria cases prescribed par-
enteral anti-malarials had no signs of severe malaria doc-
umented (and thus were able to eat and drink). Despite 
Table 4 Anti-malarial drugs prescription in children with a positive malaria test across 5 Kenyan County Hospitals
a Either a combination of artesunate or quinine or artemether lumefantrine with artemether or artemether only prescribed
Type of anti-
malarial
Overall (n = 6745) 
(%)
Hospitals
H1 (n = 1642) (%) H3 (n = 1760) (%) H7 (n = 909) (%) H8 (n = 1347) (%) H13 (n = 1087) (%)
Quinine 3184 (47.2) 1075 (65.5) 946 (53.8) 587 (64.9) 13 (1.0) 563 (51.8)
Artesunate 3108 (46.1) 478 (29.1) 739 (42.0) 244 (26.8) 1199 (89.0) 448 (41.2)
Quinine and artesu-
nate
158 (2.3) 56 (3.4) 26 (1.5) 54 (5.9) 2 (0.2) 20 (1.8)
Coartem 
(Artemether-lume-
fantrine)
250 (3.7) 33 (2.0) 18 (1.0) 19 (2.1) 124 (9.2) 56 (5.2)
Other anti-malarialsa 45 (0.7) 0 31 (1.8) 5 (0.6) 9 (0.7) 0
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this there were very low rates of giving the recommended 
ACT, AL to these ‘non-severe’ cases, signifying potential 
overuse of injectable anti-malarials in children [21]. This 
may be attributed to clinicians’ preference for parenteral 
drugs and the belief that they are ‘stronger’ [29]. On a 
positive note most of the dosing per body weight of both 
quinine and artesunate was correct, similar to a recent 
study in Uganda [21], but representing a considerable 
improvement from earlier Kenyan studies and potentially 
attributable to efforts to promote national paediatric 
guidelines in Kenya [26].
These data show high rates of presumptive treatment 
among children admitted with a negative malaria test or 
without a test done. Some reasons for this might include; 
associating malaria with high mortality [30], mistrust of 
negative test results, and concerns about missing possi-
ble malaria cases with potentially fatal consequences [30, 
31]. Similar results have been reported in various stud-
ies across Africa [20, 21, 28, 30, 32–34]. The trend seems 
to be different from outpatient studies done immediately 
after the 2010 new treatment guidelines in Uganda [35] 
and Tanzania [36], and recent findings, that reported 
a decrease in prescribing anti-malarials to malaria test 
negative patients in Kenya [13]. Worth noting is the 
low rate of repeat testing of negative cases that were 
started on anti-malarials despite the national guidelines’ 
Fig. 2 Anti-malarial drugs prescription pattern in children with admission diagnosis of malaria per hospital
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recommendation of repeat testing to confirm absence 
of malaria and stopping treatment if the results are still 
negative [10, 37]. This ‘over-treatment’ of malaria might 
lead to missing potentially treatable alternative causes of 
febrile illness with a negative malaria test that has been 
associated with high mortality [38].
As clinical features of malaria often overlap with other 
causes of febrile illness in children [39] or there might 
be co-infection with other diseases [40], it is important 
that health systems can support and that clinicians per-
form other laboratory investigations to identify and treat 
other causes of disease. Of some concern is the low use 
or availability of blood glucose testing in this population 
given that hypoglycaemia is common. The findings also 
revealed infrequent use in most hospitals of other tests 
(x-rays, microbiology tests, HIV test) to identify other 
causes of severe febrile illness in children admitted with 
clinical malaria. Anecdotally inability to conduct blood 
culture or lumbar puncture is a common problem under-
lying limited use of these investigations.
The study had some limitations. Firstly, the inclusion 
of patients in the analysis depended on the clinicians’ 
diagnosis of malaria, and further analysis relied on 
their documentation of testing and laboratory records. 
Similarly, the study relied on documentation in the case 
record of symptoms, signs and treatments to examine 
practices. The potential challenges of using such routine 
information that often has missing data were minimised 
through use of standardized record forms to record 
clinical information, timing data collection during dis-
charge, data quality checks implemented within CIN, 
feedback to and development of partnerships with hos-
pitals in the CIN all of which improved data availability 
and quality [17]. The study only captures data from five 
hospitals, hence generalizing results to other facilities 
in Kenya should be done with caution. Lastly, data on 
treatment preceding hospitalization were not available. 
Conceivably these information may have influenced 
some clinical decisions and practices which we assessed. 
The potential threat to reported findings posed by pre-
admission investigations not recorded in the CIN data is 
minimal because from our experience clinicians rarely 
use investigations conducted outside their facility as a 
basis for treatment for acute medical illnesses because 
these investigations are often perceived as unreliable, 
and also the essential investigations are readily avail-
able within facilities at minimal costs or for diseases like 
malaria these investigations are provided at no cost to 
patients. Despite these limitations, the findings from 
this study can provide an insight into the quality of rou-
tine inpatient malaria case management and the extent 
to which national and international policies are influ-
encing practice.
Conclusions
There is evidence of improvements in malaria case man-
agement over the initial 24  months of Clinical Infor-
mation Network activities but presumptive malaria 
treatment for test negative results, and overuse of inject-
able instead of oral anti-malarials are still common prac-
tices. Three years after national policy change of the 
severe malaria first-line treatment to injectable artesu-
nate, there is a gradual transition to use of artesunate. 
The findings suggest continued need for improvement in 
dissemination and implementation of guidelines for inpa-
tient care and improved, reliable access to recommended 
investigations and drugs. Finally, efforts to improve clini-
cal information could help track progress.
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